Scholar Rock Holding Corporation (SRRK)
NASDAQ: SRRK · Real-Time Price · USD
44.78
+2.69 (6.39%)
Dec 20, 2024, 4:00 PM EST - Market closed
Scholar Rock Holding Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
150
Market Cap
4.19B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Option Care Health | 4.78B |
Integer Holdings | 1.71B |
Apellis Pharmaceuticals | 715.22M |
Guardant Health | 692.26M |
Ultragenyx Pharmaceutical | 522.75M |
ADMA Biologics | 382.81M |
Axsome Therapeutics | 338.46M |
TG Therapeutics | 264.79M |
SRRK News
- 8 days ago - Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 26 days ago - Scholar Rock Stock Jumps As Rival Biohaven's Muscle-Wasting Drug Flunks Pivotal Study - Benzinga
- 5 weeks ago - Scholar Rock Holding Corporation (SRRK) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Scholar Rock Reports Third Quarter 2024 Financial Results and Highlights Business Progress - Business Wire
- 6 weeks ago - Scholar Rock Announces New Preclinical Data for SRK-439 Showing Significant Lean Mass Increase and Enhanced Fat Mass Loss with Metformin - Business Wire
- 7 weeks ago - Scholar Rock to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024 - Business Wire
- 7 weeks ago - Scholar Rock to Participate in Upcoming Investor Conferences - Business Wire
- 7 weeks ago - Scholar Rock to Present New Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 39th Annual Meeting - Business Wire